全文获取类型
收费全文 | 2038596篇 |
免费 | 150198篇 |
国内免费 | 6057篇 |
专业分类
耳鼻咽喉 | 27243篇 |
儿科学 | 66336篇 |
妇产科学 | 57356篇 |
基础医学 | 296053篇 |
口腔科学 | 56358篇 |
临床医学 | 188682篇 |
内科学 | 397377篇 |
皮肤病学 | 41546篇 |
神经病学 | 167519篇 |
特种医学 | 76938篇 |
外国民族医学 | 669篇 |
外科学 | 297510篇 |
综合类 | 44579篇 |
现状与发展 | 1篇 |
一般理论 | 685篇 |
预防医学 | 165543篇 |
眼科学 | 45754篇 |
药学 | 148629篇 |
6篇 | |
中国医学 | 4518篇 |
肿瘤学 | 111549篇 |
出版年
2019年 | 16342篇 |
2018年 | 22953篇 |
2017年 | 17573篇 |
2016年 | 19062篇 |
2015年 | 21695篇 |
2014年 | 30202篇 |
2013年 | 46816篇 |
2012年 | 63766篇 |
2011年 | 67929篇 |
2010年 | 40033篇 |
2009年 | 37266篇 |
2008年 | 62925篇 |
2007年 | 66630篇 |
2006年 | 66849篇 |
2005年 | 64982篇 |
2004年 | 61935篇 |
2003年 | 59355篇 |
2002年 | 58052篇 |
2001年 | 91010篇 |
2000年 | 93717篇 |
1999年 | 79109篇 |
1998年 | 22433篇 |
1997年 | 20430篇 |
1996年 | 20147篇 |
1995年 | 19033篇 |
1994年 | 17940篇 |
1993年 | 16929篇 |
1992年 | 62910篇 |
1991年 | 61253篇 |
1990年 | 59565篇 |
1989年 | 56879篇 |
1988年 | 52778篇 |
1987年 | 51666篇 |
1986年 | 49308篇 |
1985年 | 47207篇 |
1984年 | 35622篇 |
1983年 | 30296篇 |
1982年 | 18317篇 |
1979年 | 32540篇 |
1978年 | 23059篇 |
1977年 | 19164篇 |
1976年 | 18600篇 |
1975年 | 19514篇 |
1974年 | 23663篇 |
1973年 | 22951篇 |
1972年 | 21448篇 |
1971年 | 19910篇 |
1970年 | 18703篇 |
1969年 | 17269篇 |
1968年 | 16485篇 |
排序方式: 共有10000条查询结果,搜索用时 281 毫秒
941.
Penetrating keratoplasty was performed in 106 cases of post-inflammatory corneal opacity with vascularization. Donor material obtained post mortem was preserved in a moist chamber, MK-medium at 4 degrees C or in culture medium at room temperature. 55.7% of patients gained a useful vision after keratoplasty. The post-operative spherical error of refraction was found to be -1.4 +/- 3.6 D and the astigmatic error of refraction -3.3 +/- 2.0 D. The post-operative visual acuity was found to be 0.2 +/- 0.2. The ocular pathology associated with keratoplasty is discussed. 相似文献
942.
943.
944.
945.
Of 7 plasmids we tested, the plasmid pORF2 was eliminated in vitro with the most efficiency by treatment with subinhibitory concentrations of novobiocin, coumermycin and 10 quinolones. It showed a cure rate of 43% by enoxacin; 12% by novobiocin, pefloxacin, ciprofloxacin and CI-934; 7% by coumermycin and ofloxacin; 9% by amifloxacin; and 4% by AM-833. On the other hand, pSC194, pBR322 and pMH612 were poorly cured in vitro by quinolones, except pSC194 which was cured 33% by enoxacin. R1, pP1603, and pUB110 were unaffected by the treatment. Mice were challenged intraperitoneally with a 2XLD50 of Escherichia coli carrying the ORF2 plasmid and were treated per os with 1 X or 1/2 X ED50 of either enoxacin or CI-934. The frequency of loss of ampicillin resistance determined 3 h after treatment shows curing effects of 92% for CI-934, 89% for enoxacin and 20% for untreated control. 相似文献
946.
947.
948.
H L Elliott P A Meredith L Campbell J L Reid 《Clinical pharmacology and therapeutics》1988,43(5):554-560
An exaggerated fall in blood pressure has been reported with the combination of an alpha 1-blocker and a calcium antagonist. This study investigated, in a placebo-controlled, randomized crossover trial, the clinical usefulness of the combination of prazosin (2 mg b.i.d.) and verapamil (160 mg b.i.d.). Therapeutic efficacy was monitored at regular outpatient visits: average supine and erect blood pressures were, respectively, 175/99 and 176/103 mm Hg with placebo, 160/91 and 164/96 mm Hg with single drug treatment, and 152/84 and 152/89 mm Hg with combination therapy. This significant and clinically useful reduction in blood pressure had an overall magnitude of approximately 28/18 mm Hg (supine) and 29/19 mm Hg (erect). Further measurements were made during a series of intensive study days, and the most important additional finding was a pharmacokinetic interaction that resulted in increased peak concentrations and bioavailability of prazosin. In conclusion, the combination of prazosin and verapamil proved effective in the treatment of 12 patients with essential hypertension who had been poorly responsive to conventional treatment with a beta-blocker and thiazide diuretic. 相似文献
949.
A G Antoshechkin L A Tatur VYuMaximova 《Clinica chimica acta; international journal of clinical chemistry》1988,177(3):239-244
In order to study metabolic distinctions in phenylketonuria, urinary metabolites in the form of trimethylsilyl derivatives have been characterized by high resolution gas chromatography and mass spectrometry. A previously unknown metabolite has been found in the urine of some untreated phenylketonuric infants between 2 and 5 yr of age. The metabolite was absent in healthy children of the same age. The metabolite appeared to be present in the urine of apparently healthy adults (25-32 yr old). The metabolite was identified as methoxyacetylcarbamide on the basis of mass fragmentation analysis and compared with synthetic methoxyacetylcarbamide. Their retention times and mass spectra coincided. 相似文献
950.